Respiri Limited (RSH.AX)
AUD 0.03
(-20.59%)
AUD 0.03
(-20.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 413.68 Thousand AUD | 17760.11% |
| 2023 | 2968.00 AUD | 100.26% |
| 2022 | -1.14 Million AUD | 85.36% |
| 2021 | -7.83 Million AUD | -194.45% |
| 2020 | -2.65 Million AUD | -632.12% |
| 2019 | 499.78 Thousand AUD | 120.67% |
| 2018 | -2.41 Million AUD | -54.74% |
| 2017 | -1.56 Million AUD | 65.28% |
| 2016 | -4.5 Million AUD | -49.64% |
| 2015 | -3 Million AUD | 63.36% |
| 2014 | -8.21 Million AUD | -509.77% |
| 2013 | -1.34 Million AUD | -1.39% |
| 2012 | -1.32 Million AUD | -1.23% |
| 2011 | -1.31 Million AUD | 41.81% |
| 2010 | -2.25 Million AUD | 14.44% |
| 2009 | -2.63 Million AUD | 21.81% |
| 2008 | -3.37 Million AUD | -472.72% |
| 2007 | -588.51 Thousand AUD | -41.72% |
| 2006 | -415.26 Thousand AUD | 61.41% |
| 2005 | -1.07 Million AUD | 17.01% |
| 2004 | -1.29 Million AUD | -244.78% |
| 2003 | -376.09 Thousand AUD | 66.57% |
| 2002 | -1.12 Million AUD | 90.92% |
| 2001 | -12.39 Million AUD | -55.47% |
| 2000 | -7.97 Million AUD | 50.76% |
| 1999 | -16.19 Million AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 413.68 Thousand AUD | 0.0% |
| 2024 Q2 | -793.66 Thousand AUD | 0.0% |
| 2024 FY | -646.47 Thousand AUD | -21881.5% |
| 2023 FY | 2968.00 AUD | 100.26% |
| 2023 Q2 | -230.07 Thousand AUD | 0.0% |
| 2023 Q4 | 2968.00 AUD | 0.0% |
| 2022 Q2 | -5.08 Million AUD | 0.0% |
| 2022 Q4 | -1.14 Million AUD | 0.0% |
| 2022 FY | -1.14 Million AUD | 85.36% |
| 2021 FY | -7.83 Million AUD | -194.45% |
| 2021 Q2 | -11.3 Million AUD | 0.0% |
| 2021 Q4 | -7.83 Million AUD | 0.0% |
| 2020 FY | -2.65 Million AUD | -632.12% |
| 2020 Q4 | -2.65 Million AUD | 0.0% |
| 2020 Q2 | -609.06 Thousand AUD | 0.0% |
| 2019 Q4 | 499.78 Thousand AUD | 0.0% |
| 2019 FY | 499.78 Thousand AUD | 120.67% |
| 2019 Q2 | -2.99 Million AUD | 0.0% |
| 2018 Q4 | -2.41 Million AUD | 0.0% |
| 2018 Q2 | -1.05 Million AUD | 0.0% |
| 2018 FY | -2.41 Million AUD | -54.74% |
| 2017 Q2 | -2.71 Million AUD | 0.0% |
| 2017 Q4 | -1.56 Million AUD | 0.0% |
| 2017 FY | -1.56 Million AUD | 65.28% |
| 2016 FY | -4.5 Million AUD | -49.64% |
| 2016 Q2 | -1.42 Million AUD | 0.0% |
| 2016 Q4 | -4.5 Million AUD | 0.0% |
| 2015 Q2 | -5.4 Million AUD | 0.0% |
| 2015 FY | -3 Million AUD | 63.36% |
| 2015 Q4 | -3 Million AUD | 0.0% |
| 2014 Q4 | -8.21 Million AUD | 0.0% |
| 2014 Q2 | -10.04 Million AUD | 0.0% |
| 2014 FY | -8.21 Million AUD | -509.77% |
| 2013 Q4 | -1.34 Million AUD | 0.0% |
| 2013 FY | -1.34 Million AUD | -1.39% |
| 2013 Q1 | -3.79 Million AUD | -185.87% |
| 2013 Q2 | -3.79 Million AUD | 0.0% |
| 2013 Q3 | -1.34 Million AUD | 64.53% |
| 2012 Q4 | -1.32 Million AUD | 0.0% |
| 2012 FY | -1.32 Million AUD | -1.23% |
| 2011 FY | -1.31 Million AUD | 41.81% |
| 2011 Q4 | -1.31 Million AUD | 0.0% |
| 2010 FY | -2.25 Million AUD | 14.44% |
| 2010 Q4 | -2.25 Million AUD | 0.0% |
| 2009 FY | -2.63 Million AUD | 21.81% |
| 2009 Q4 | -2.63 Million AUD | 0.0% |
| 2008 FY | -3.37 Million AUD | -472.72% |
| 2008 Q4 | -3.37 Million AUD | 0.0% |
| 2007 Q4 | -588.35 Thousand AUD | 0.0% |
| 2007 FY | -588.51 Thousand AUD | -41.72% |
| 2006 Q4 | -415.26 Thousand AUD | 0.0% |
| 2006 FY | -415.26 Thousand AUD | 61.41% |
| 2005 FY | -1.07 Million AUD | 17.01% |
| 2005 Q4 | -1.07 Million AUD | 0.0% |
| 2004 Q4 | -1.29 Million AUD | 0.0% |
| 2004 FY | -1.29 Million AUD | -244.78% |
| 2003 FY | -376.09 Thousand AUD | 66.57% |
| 2003 Q4 | -376.09 Thousand AUD | 0.0% |
| 2002 FY | -1.12 Million AUD | 90.92% |
| 2002 Q4 | -1.12 Million AUD | 0.0% |
| 2001 Q4 | -12.39 Million AUD | 0.0% |
| 2001 FY | -12.39 Million AUD | -55.47% |
| 2000 FY | -7.97 Million AUD | 50.76% |
| 1999 FY | -16.19 Million AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 101.623% |
| Adherium Limited | -6.1 Million AUD | 106.777% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 111.04% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 111.481% |
| Anteris Technologies Ltd | -28.49 Million AUD | 101.452% |
| Control Bionics Limited | -19.02 Thousand AUD | 2274.792% |
| CardieX Limited | 2.74 Million AUD | 84.937% |
| Compumedics Limited | 5.08 Million AUD | 91.868% |
| Cochlear Limited | -269.9 Million AUD | 100.153% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 40.782% |
| Cyclopharm Limited | -7.49 Million AUD | 105.516% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 102.635% |
| Nova Eye Medical Limited | -2.8 Million AUD | 114.764% |
| HeraMED Limited | -799.34 Thousand AUD | 151.753% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 97.144% |
| ImpediMed Limited | -23.48 Million AUD | 101.761% |
| InhaleRx Limited | -155.54 Thousand AUD | 365.963% |
| LBT Innovations Limited | -604 Thousand AUD | 168.492% |
| Micro-X Limited | 826.99 Thousand AUD | 49.977% |
| Neurotech International Limited | -2.11 Million AUD | 119.602% |
| OncoSil Medical Limited | -4.43 Million AUD | 109.337% |
| PolyNovo Limited | -30.52 Million AUD | 101.355% |
| SomnoMed Limited | -15.16 Million AUD | 102.728% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 107.8% |
| Uscom Limited | -1.53 Million AUD | 127.027% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 110.132% |